Italy's GVS Q1 revenue rises on healthcare & life sciences growth

GVS

14/05/2026 12:22

Overview

Italy filtration solutions provider's Q1 revenue grew 3.9% yr/yr at constant FX

Adjusted EBITDA for Q1 rose 0.3% yr/yr, margin increased to 24.6%

Company launched voluntary partial tender offer for up to 12.29% of share capital

Outlook

GVS expects low single-digit revenue growth at constant FX for FY 2026

Company sees adjusted EBITDA margin expansion of 20–50 bps in FY 2026

GVS forecasts leverage ratio of about 1.8x at end-2026

Result Drivers

HEALTHCARE & LIFE SCIENCES - Division accounted for 68.7% of revenue and grew 3.5% yr/yr at constant FX, with all sub-divisions reporting growth

MARGIN IMPROVEMENT - Adjusted EBITDA margin increased to 24.6%, up 57 basis points yr/yr

HIGHER DEPRECIATION & AMORTIZATION - Adjusted EBIT declined 8.1% yr/yr due to increased depreciation and amortization related to property, plant and equipment and right-of-use assets

Company press release: ID:nBIA1zk1Td

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
EUR 105 mln
EUR 106.41 mln (2 Analysts)
Q1 Adjusted EBITDA
Beat
EUR 25.90 mln
EUR 25.32 mln (2 Analysts)
Q1 Adjusted EBIT
Miss
EUR 17.20 mln
EUR 17.44 mln (2 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for GVS SpA is €4.70, about 11.2% above its May 13 closing price of €4.23

The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 14 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)